» Articles » PMID: 19378973

Membrane-dependent Interaction of Factor Xa and Prothrombin with Factor Va in the Prothrombinase Complex

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2009 Apr 22
PMID 19378973
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Because all three protein components of prothrombinase, factors (f) Xa and Va and prothrombin, bind to negatively charged membrane phospholipids, the exact role of the membrane in the prothrombinase reaction has not been fully understood. In this study, we prepared deletion derivatives of fXa and prothrombin in which both the Gla and first EGF-like domains of the protease (E2-fXa) as well as the Gla and both kringle domains of the substrate (prethrombin-2) had been deleted. The fVa-mediated catalytic activity of E2-fXa toward prethrombin-2 was analyzed in both the absence and presence of phospholipids composed of 80% phosphatidylcholine (PC) and 20% phosphatidylserine (PS). PCPS markedly accelerated the initial rate of prethrombin-2 activation by E2-fXa, with the cofactor exhibiting saturation only in the presence of phospholipids (apparent K(d) of approximately 60 nM). Competitive kinetic studies in the presence of the two exosite-1-specific ligands Tyr(63)-sulfated hirudin(54-65) and TM456 suggested that while both peptides are highly effective inhibitors of the fVa-mediated activation of prethrombin-2 by E2-fXa in the absence of PCPS, they are ineffective competitors in the presence of phospholipids. Since neither E2-fXa nor prethrombin-2 can interact with membranes, these results suggest that interaction of fVa with PCPS improves the affinity of the activation complex for proexosite-1 of the substrate. Direct binding studies employing OG(488)-EGR-labeled fXa and E2-fXa revealed that the interaction of the Gla domain of fXa with PCPS also induces conformational changes in the protease to facilitate its high-affinity interaction with fVa.

Citing Articles

Extracellular vesicle tissue factor and tissue factor pathway inhibitor are independent discriminators of sepsis-induced coagulopathy.

Tobiasch A, Lehner G, Feistritzer C, Peer A, Zassler B, Neumair V Res Pract Thromb Haemost. 2024; 8(7):102596.

PMID: 39624584 PMC: 11609531. DOI: 10.1016/j.rpth.2024.102596.


Mice with Reduced PAR4 Reactivity show Decreased Venous Thrombosis and Platelet Procoagulant Activity.

Knauss E, Guci J, Luc N, Disharoon D, Huang G, Sen Gupta A bioRxiv. 2024; .

PMID: 39463946 PMC: 11507748. DOI: 10.1101/2024.10.14.617127.


Exploring microplastic impact on whole blood clotting dynamics utilizing thromboelastography.

Christodoulides A, Hall A, Alves N Front Public Health. 2023; 11:1215817.

PMID: 37521965 PMC: 10372794. DOI: 10.3389/fpubh.2023.1215817.


Mapping the prothrombin-binding site of pseutarin C by site-directed PEGylation.

Ustok F, Huntington J Blood. 2022; 139(19):2972-2982.

PMID: 35148539 PMC: 9101250. DOI: 10.1182/blood.2021014878.


ptFVa ( Venom-Derived Factor Va) Retains Structural Integrity Following Proteolysis by Activated Protein C.

Schreuder M, Liu X, Cheung K, Reitsma P, Nicolaes G, Bos M Arterioscler Thromb Vasc Biol. 2021; 41(8):2263-2276.

PMID: 34162230 PMC: 8288481. DOI: 10.1161/ATVBAHA.121.316038.


References
1.
Kalafatis M, Beck D . Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X. Biochemistry. 2002; 41(42):12715-28. DOI: 10.1021/bi026208+. View

2.
Hertzberg M, Ben-Tal O, Furie B, Furie B . Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding. J Biol Chem. 1992; 267(21):14759-66. View

3.
Yegneswaran S, Mesters R, Fernandez J, Griffin J . Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complex. J Biol Chem. 2004; 279(47):49019-25. DOI: 10.1074/jbc.M406645200. View

4.
Rudolph A, Porche-Sorbet R, Miletich J . Definition of a factor Va binding site in factor Xa. J Biol Chem. 2000; 276(7):5123-8. DOI: 10.1074/jbc.M006961200. View

5.
Mann K, Jenny R, Krishnaswamy S . Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem. 1988; 57:915-56. DOI: 10.1146/annurev.bi.57.070188.004411. View